Caisson Biotech, LLC, a wholly owned subsidiary spun out of Heparinex LLC.,developed a novel, heparosan-based drug delivery technology, HEPtuneâ¢. HEPtune conjugates the polymer heparosan to a drug which enhances the therapeutic properties of pharmaceuticals by increasing product half-life, reducing immunogenicity, and increasing stability.